---
figid: PMC9513621__gr1
figtitle: Platinum@polymer-catechol nanobraker enables radio-immunotherapy for crippling
  melanoma tumorigenesis, angiogenesis, and radioresistance
organisms:
- NA
pmcid: PMC9513621
filename: gr1.jpg
figlink: /pmc/articles/PMC9513621/figure/fig1/
number: F1
caption: The fabrication process and anti-tumor mechanism related to APTP nanobraker.
  a Schematic illustration of amphiphilic PEG-polyphenol-assisted assembly of APTP
  NPs. b Mechanism illustration of APTP NPs against melanoma-intrinsic tumor aggression.
  aPD-L1-adsorbed on the nanobraker actively target melanoma cells and blocking melanoma-PD-L1
  receptor. Then, the loaded mTOR inhibitor TAK228 was released to intercede the melanoma
  cell-intrinsic PD-1/PD-L1 interaction via dampening protumorigenic mTOR pathway.
  The inhibition of mTOR signaling was beneficial to downregulate protumorigenic cMYC
  and proangiogenic HIF-1α. Additionally, radiosensitizing high-Z metal Pt cooperating
  with TAK228 ameliorates radiotherapy to accelerate cell death. Besides, aPD-L1-adsorbed
  on the nanobraker blocked the lymphocyte-PD-1:melanoma-PD-L1 interaction to facilitate
  the effective infiltration of cytotoxic T lymphocytes.
papertitle: A platinum@polymer-catechol nanobraker enables radio-immunotherapy for
  crippling melanoma tumorigenesis, angiogenesis, and radioresistance.
reftext: Wenxi Li, et al. Bioact Mater. 2023 Apr;22:34-46.
year: '2023'
doi: 10.1016/j.bioactmat.2022.09.006
journal_title: Bioactive Materials
journal_nlm_ta: Bioact Mater
publisher_name: KeAi Publishing
keywords: platinum@polymer-catechol nanobrakers | Melanoma PD-1:PD-L1 interaction
  blockade | Radio-sensitization effect | Anti-tumorigenesis | Anti-angiogenesis
automl_pathway: 0.9535224
figid_alias: PMC9513621__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC9513621__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9513621__gr1.html
  '@type': Dataset
  description: The fabrication process and anti-tumor mechanism related to APTP nanobraker.
    a Schematic illustration of amphiphilic PEG-polyphenol-assisted assembly of APTP
    NPs. b Mechanism illustration of APTP NPs against melanoma-intrinsic tumor aggression.
    aPD-L1-adsorbed on the nanobraker actively target melanoma cells and blocking
    melanoma-PD-L1 receptor. Then, the loaded mTOR inhibitor TAK228 was released to
    intercede the melanoma cell-intrinsic PD-1/PD-L1 interaction via dampening protumorigenic
    mTOR pathway. The inhibition of mTOR signaling was beneficial to downregulate
    protumorigenic cMYC and proangiogenic HIF-1α. Additionally, radiosensitizing high-Z
    metal Pt cooperating with TAK228 ameliorates radiotherapy to accelerate cell death.
    Besides, aPD-L1-adsorbed on the nanobraker blocked the lymphocyte-PD-1:melanoma-PD-L1
    interaction to facilitate the effective infiltration of cytotoxic T lymphocytes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mtor
  - Tor
  - Akt
  - foxo
  - Myc
  - Crtc
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Thor
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
---
